# Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections

> **NCT00542399** · PHASE4 · COMPLETED · sponsor: **Rabin Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Levemir (insulin detemir)
- **DRUG:** Levemir twice a day

## Key facts

- **NCT ID:** NCT00542399
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-01
- **Final completion:** 2010-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00542399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00542399, "Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00542399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*